期刊
JOURNAL OF NEUROCHEMISTRY
卷 79, 期 6, 页码 1217-1224出版社
BLACKWELL PUBLISHING LTD
DOI: 10.1046/j.1471-4159.2001.00669.x
关键词
brain pathology; cerebral energy metabolism; 2-deoxyglucose; genetic model; lysosomal disorder
Fabry disease is an X-linked lysosomal disorder characterized by deficient alpha -galactosidase A activity and intracellular accumulations of glycosphingolipids, mainly globotriaosylceramide (Gb3). Clinically, patients occasionally present CNS dysfunction. To examine the pathophysiology underlying brain dysfunction, we examined glucose utilization (CMRglc) and cerebral blood flow (CBF) globally and locally in 18 brain structures in the a-galactosidase A gene knockout mouse. Global CMRglc was statistically significantly reduced by 22% in Fabry mice (p < 0.01). All 18 structures showed decreases in local CMRglc ranging from 14% to 33%. The decreases in all structures of the diencephalon, caudate-putamen, brain stem, and cerebellar cortex were statistically significant (p < 0.05). Global cerebral blood flow (CBF) and local CBF measured in the same 18 structures were lower in Fabry mice than in control mice, but none statistically significantly. Histological examination of brain revealed no cerebral infarcts but abundant Gb3 deposits in the walls of the cerebral vessels with neuronal deposits localized to the medulla oblongata. These results indicate an impairment in cerebral energy metabolism in the Fabry mice, but one not necessarily due to circulatory insufficiency.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据